Literature DB >> 7877965

Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.

H P Roost1, M F Bachmann, A Haag, U Kalinke, V Pliska, H Hengartner, R M Zinkernagel.   

Abstract

Affinity maturation of IgG antibodies in adaptive immune responses is a well-accepted mechanism to improve effector functions of IgG within 2 weeks to several months of antigen encounter. This concept has been defined mainly for IgG responses against chemically defined haptens. We have evaluated this concept in a viral system and analyzed neutralizing IgG antibody responses against vesicular stomatitis virus (a close relative of rabies virus) with a panel of monoclonal antibodies obtained early (day 6 or 12) and late (day 150) after hyperimmunization. These neutralizing IgG antibodies recognize a single major antigenic site with high affinities (Ka of 10(8)-10(10) liter.mol-1) and with rapid on-rates already on day 6 of a primary response and with no evidence for further antigen dose- and time-dependent overall improvement of affinity. This type of IgG response is probably representative for viruses or bacterial toxins which are crucially controlled by neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7877965      PMCID: PMC42498          DOI: 10.1073/pnas.92.5.1257

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  The role of somatic hypermutation in the generation of antibody diversity.

Authors:  D L French; R Laskov; M D Scharff
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

Review 2.  The immunopathogenesis of HIV infection.

Authors:  Z F Rosenberg; A S Fauci
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  Limitations of different ELISA procedures for localizing epitopes in viral coat protein subunits.

Authors:  E L Dekker; C Porta; M H Van Regenmortel
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  A model in mice for the pathogenesis and treatment of rabies.

Authors:  G M Baer; W F Cleary
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

5.  The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus.

Authors:  M E Frankel; W Gerhard
Journal:  Mol Immunol       Date:  1979-02       Impact factor: 4.407

6.  Pathogenesis of lesions in lymphoid tissue of mice infected with lymphocytic choriomeningitis (LCM) virus.

Authors:  C A Mims; F A Tosolini
Journal:  Br J Exp Pathol       Date:  1969-12

7.  Studies on the immunogenicity and tolerogenicity of T-independent antigens.

Authors:  R Z Dintzis; M H Middleton; H M Dintzis
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Molecular determinants of immunogenicity: the immunon model of immune response.

Authors:  H M Dintzis; R Z Dintzis; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

9.  Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo.

Authors:  L Lefrancois
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

10.  Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.

Authors:  C Wagener; B R Clark; K J Rickard; J E Shively
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

View more
  61 in total

1.  Kinetics of association of anti-lysozyme monoclonal antibody D44.1 and hen-egg lysozyme.

Authors:  G Altobelli; S Subramaniam
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs.

Authors:  A F Ochsenbein; D D Pinschewer; S Sierro; E Horvath; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 3.  Genetic and structural determinants of virus neutralizing antibodies.

Authors:  J E Crowe; R O Suara; S Brock; N Kallewaard; F House; J H Weitkamp
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation.

Authors:  Claire L Adams; Megan K L Macleod; E James Milner-White; Robert Aitken; Paul Garside; David I Stott
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

5.  MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

Authors:  Surender Khurana; Nitin Verma; Jonathan W Yewdell; Anne Katrin Hilbert; Flora Castellino; Maria Lattanzi; Giuseppe Del Giudice; Rino Rappuoli; Hana Golding
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

6.  Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.

Authors:  E B Flanagan; L A Ball; G W Wertz
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Basic problems of serological laboratory diagnosis.

Authors:  W Fierz
Journal:  Mol Biotechnol       Date:  1999-12-01       Impact factor: 2.695

8.  Structural mechanism for affinity maturation of an anti-lysozyme antibody.

Authors:  Ana Cauerhff; Fernando A Goldbaum; Bradford C Braden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

9.  Judging a virus by its cover.

Authors:  Eva Szomolanyi-Tsuda; Raymond M Welsh
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Enhanced HIV-1 neutralization by antibody heteroligation.

Authors:  Hugo Mouquet; Malte Warncke; Johannes F Scheid; Michael S Seaman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.